{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:55:11Z","timestamp":1770126911375,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"DOI":"10.7759\/cureus.102854","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T02:23:47Z","timestamp":1770085427000},"source":"Crossref","is-referenced-by-count":0,"title":["Crisaborole as a Potential Treatment for Pediatric Alopecia Areata: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Qiannan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70076","article-title":"Global burden of alopecia areata and associated diseases: a trend analysis from 1990 to 2021","volume":"24","author":"Zhou J","year":"2025","unstructured":"Zhou J, Liang L, Zhang H, Liu M, Zhu Z, Leng L, Li J. Global burden of alopecia areata and associated diseases: a trend analysis from 1990 to 2021. J Cosmet Dermatol. 2025, 24:e70076. 10.1111\/jocd.70076","journal-title":"J Cosmet Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.03.085","article-title":"Baricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients","volume":"93","author":"Valido K","year":"2025","unstructured":"Valido K, Craiglow BG. Baricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients. J Am Acad Dermatol. 2025, 93:509-10. 10.1016\/j.jaad.2025.03.085","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00664-9","article-title":"Alopecia areata","volume":"11","author":"Ungar B","year":"2025","unstructured":"Ungar B, Renert-Yuval Y, Dlova NC, et al.. Alopecia areata. Nat Rev Dis Primers. 2025, 11:77. 10.1038\/s41572-025-00664-9","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20594","article-title":"Glucocorticoids promote CCL20 expression in keratinocytes","volume":"185","author":"Wang L","year":"2021","unstructured":"Wang L, Yang M, Wang X, Cheng B, Ju Q, Eichenfield DZ, Sun BK. Glucocorticoids promote CCL20 expression in keratinocytes. Br J Dermatol. 2021, 185:1200-8. 10.1111\/bjd.20594","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-023-02791-z","article-title":"Linear hair growth rates in preschool children","volume":"95","author":"Ruiz MO","year":"2024","unstructured":"Ruiz MO, Rovnaghi CR, Tembulkar S, Qin F, Truong L, Shen S, Anand KJ. Linear hair growth rates in preschool children. Pediatr Res. 2024, 95:359-66. 10.1038\/s41390-023-02791-z","journal-title":"Pediatr Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ds.DS-D-24-00285","article-title":"Real-world evidence in alopecia areata treatment: a narrative review","volume":"20","author":"Tsai CF","year":"2025","unstructured":"Tsai CF, Lin FL, Cheng TT, Lo Y. Real-world evidence in alopecia areata treatment: a narrative review. Dermatol Sin. 2025, 20:0. 10.4103\/ds.DS-D-24-00285","journal-title":"Dermatol Sin"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.12445","article-title":"Real-world treatment patterns among patients with alopecia areata in the USA: a retrospective claims analysis","volume":"103","author":"Done N","year":"2023","unstructured":"Done N, Bartolome L, Swallow E, Gao W, Carley C, Wang T, Mostaghimi A. Real-world treatment patterns among patients with alopecia areata in the USA: a retrospective claims analysis. Acta Derm Venereol. 2023, 103:adv12445. 10.2340\/actadv.v103.12445","journal-title":"Acta Derm Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.064","article-title":"Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin","volume":"89","author":"Kim M","year":"2023","unstructured":"Kim M, Del Duca E, Cheng J, et al.. Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin. J Am Acad Dermatol. 2023, 89:283-92. 10.1016\/j.jaad.2023.02.064","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/exd.70153","article-title":"Orismilast, a potent and selective PDE4B\/D inhibitor, reduces protein levels of key disease driving cytokines in the skin of patients with plaque psoriasis","volume":"34","author":"Warren RB","year":"2025","unstructured":"Warren RB, Weiss A, Felding J, Sommer MO, Garcet S, Krueger JG. Orismilast, a potent and selective PDE4B\/D inhibitor, reduces protein levels of key disease driving cytokines in the skin of patients with plaque psoriasis. Exp Dermatol. 2025, 34:e70153. 10.1111\/exd.70153","journal-title":"Exp Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2023.09.008","article-title":"Alopecia areata: what's new in the epidemiology, comorbidities, and pathogenesis?","volume":"112","author":"Dainichi T","year":"2023","unstructured":"Dainichi T, Iwata M, Kaku Y. Alopecia areata: what's new in the epidemiology, comorbidities, and pathogenesis?. J Dermatol Sci. 2023, 112:120-7. 10.1016\/j.jdermsci.2023.09.008","journal-title":"J Dermatol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito T","year":"2020","unstructured":"Ito T, Kageyama R, Nakazawa S, Honda T. Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata. Exp Dermatol. 2020, 29:726-32. 10.1111\/exd.14129","journal-title":"Exp Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-025-03987-5","article-title":"Associations of inflammatory cytokines with alopecia areata: a two-sample Mendelian randomization study","volume":"317","author":"Xu Y","year":"2025","unstructured":"Xu Y, Zhan W, Zhao J. Associations of inflammatory cytokines with alopecia areata: a two-sample Mendelian randomization study. Arch Dermatol Res. 2025, 317:447. 10.1007\/s00403-025-03987-5","journal-title":"Arch Dermatol Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxaf004","article-title":"Patterning effects of FGF17 and cAMP on generation of dopaminergic progenitors for cell replacement therapy in Parkinson's disease","volume":"43","author":"Holm Nygaard A","year":"2025","unstructured":"Holm Nygaard A, Sch\u00f6rling AL, Abay-N\u00f8rgaard Z, et al.. Patterning effects of FGF17 and cAMP on generation of dopaminergic progenitors for cell replacement therapy in Parkinson's disease. Stem Cells. 2025, 43:sxaf004. 10.1093\/stmcls\/sxaf004","journal-title":"Stem Cells"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00815-y","article-title":"Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis","volume":"54","author":"Gao R","year":"2022","unstructured":"Gao R, Guo W, Fan T, et al.. Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis. Exp Mol Med. 2022, 54:1201-13. 10.1038\/s12276-022-00815-y","journal-title":"Exp Mol Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116930","article-title":"Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasis","volume":"280","author":"Li G","year":"2024","unstructured":"Li G, He D, Qian X, et al.. Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasis. Eur J Med Chem. 2024, 280:116930. 10.1016\/j.ejmech.2024.116930","journal-title":"Eur J Med Chem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S266409","article-title":"Alopecia areata: an autoimmune disease of multiple players","volume":"10","author":"Suchonwanit P","year":"2021","unstructured":"Suchonwanit P, Kositkuljorn C, Pomsoong C. Alopecia areata: an autoimmune disease of multiple players. Immunotargets Ther. 2021, 10:299-312. 10.2147\/ITT.S266409","journal-title":"Immunotargets Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.321365","article-title":"Targeting PDE4B (phosphodiesterase-4 subtype B) for cardioprotection in acute myocardial infarction via neutrophils and microcirculation","volume":"131","author":"Wan Q","year":"2022","unstructured":"Wan Q, Xu C, Zhu L, et al.. Targeting PDE4B (phosphodiesterase-4 subtype B) for cardioprotection in acute myocardial infarction via neutrophils and microcirculation. Circ Res. 2022, 131:442-55. 10.1161\/CIRCRESAHA.122.321365","journal-title":"Circ Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17185","article-title":"Efficacy of apremilast in hyperkeratotic hand and foot dermatitis: results from a randomized observer-blinded comparative study","volume":"63","author":"Bhat K","year":"2024","unstructured":"Bhat K, Patra S, Bhardwaj A, Singh S, Budania A, Bains A, Saurabh S. Efficacy of apremilast in hyperkeratotic hand and foot dermatitis: results from a randomized observer-blinded comparative study. Int J Dermatol. 2024, 63:1535-40. 10.1111\/ijd.17185","journal-title":"Int J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15751","article-title":"Safety of topical medications in the management of paediatric atopic dermatitis: an updated systematic review","volume":"89","author":"Zhao S","year":"2023","unstructured":"Zhao S, Hwang A, Miller C, Lio P. Safety of topical medications in the management of paediatric atopic dermatitis: an updated systematic review. Br J Clin Pharmacol. 2023, 89:2039-65. 10.1111\/bcp.15751","journal-title":"Br J Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15123","article-title":"Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis","volume":"47","author":"Ono R","year":"2020","unstructured":"Ono R, Yagi M, Shoji A, Fujita K, Yoshida M, Ports WC, Purohit VS. Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis. J Dermatol. 2020, 47:25-32. 10.1111\/1346-8138.15123","journal-title":"J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2024.0575","article-title":"Evaluating efficacy and safety of crisaborole in managing childhood mild to moderate atopic dermatitis: a systematic review and meta-analysis","volume":"86","author":"You J","year":"2025","unstructured":"You J, Li H, Wang Z, Zhao Y. Evaluating efficacy and safety of crisaborole in managing childhood mild to moderate atopic dermatitis: a systematic review and meta-analysis. Br J Hosp Med (Lond). 2025, 86:1-19. 10.12968\/hmed.2024.0575","journal-title":"Br J Hosp Med (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443585-crisaborole-as-a-potential-treatment-for-pediatric-alopecia-areata-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T02:23:47Z","timestamp":1770085427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443585-crisaborole-as-a-potential-treatment-for-pediatric-alopecia-areata-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.102854","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}